{Reference Type}: Journal Article
{Title}: Nuclear proteins and diabetic retinopathy: a review.
{Author}: Li B;Hussain W;Jiang ZL;Wang JY;Hussain S;Yasoob TB;Zhai YK;Ji XY;Dang YL;
{Journal}: Biomed Eng Online
{Volume}: 23
{Issue}: 1
{Year}: 2024 Jun 25
{Factor}: 3.903
{DOI}: 10.1186/s12938-024-01258-4
{Abstract}: Diabetic retinopathy (DR) is an eye disease that causes blindness and vision loss in diabetic. Risk factors for DR include high blood glucose levels and some environmental factors. The pathogenesis is based on inflammation caused by interferon and other nuclear proteins. This review article provides an overview of DR and discusses the role of nuclear proteins in the pathogenesis of the disease. Some core proteins such as MAPK, transcription co-factors, transcription co-activators, and others are part of this review. In addition, some current advanced treatment resulting from the role of nuclear proteins will be analyzes, including epigenetic modifications, the use of methylation, acetylation, and histone modifications. Stem cell technology and the use of nanobiotechnology are proposed as promising approaches for a more effective treatment of DR.